| Original language | English |
|---|---|
| Pages (from-to) | 3009-3010 |
| Number of pages | 2 |
| Journal | Annals of Surgical Oncology |
| Volume | 28 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2021 Jun |
ASJC Scopus subject areas
- Surgery
- Oncology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Author Reflections : Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio. / Takeuchi, Masashi; Hoshino, Shota; Kawakubo, Hirofumi et al.
In: Annals of Surgical Oncology, Vol. 28, No. 6, 06.2021, p. 3009-3010.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Author Reflections
T2 - Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio
AU - Takeuchi, Masashi
AU - Hoshino, Shota
AU - Kawakubo, Hirofumi
AU - Matsuda, Satoru
AU - Mayanagi, Shuhei
AU - Irino, Tomoyuki
AU - Fukuda, Kazumasa
AU - Nakamura, Rieko
AU - Wada, Norihito
AU - Kitagawa, Yuko
N1 - Funding Information: Dr. Kitagawa reports grants from TAIHO PHARMACEUTICAL CO., LTD., CHUGAI PHARMACEUTICAL CO., LTD., Yakult Honsha Co. Ltd, DAIICHI SANKYO COMPANY, Merck Serono Co., Ltd, AsahiKASEI Co., Ltd, EA Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Factory Inc., SHIONOGI & CO., LTD., KAKEN PHARMACEUTICAL CO., LTD., Kowa Pharmaceutical Co., Ltd., Astellas Pharma Inc, MEDICON INC., DAINIPPON SUMITOMO PHARMA Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Kyouwa Hakkou Kirin Co., Ltd., Pfizer Japan Inc., ONO PHARMACEUTICAL CO., LTD., NIHON PHARMACEUTICAL CO., LTD., Japan Blood Products Organization, Medtronic Japan Co., Ltd., Sanofi K.K., Eisai Co., Ltd, TSUMURA & CO., KCI Licensing, Inc., ABBOTT JAPAN CO., LTD, and FUJIFILM Toyama Chemical Co., Ltd. outside the submitted work.
PY - 2021/6
Y1 - 2021/6
UR - http://www.scopus.com/inward/record.url?scp=85102055276&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102055276&partnerID=8YFLogxK
U2 - 10.1245/s10434-021-09638-z
DO - 10.1245/s10434-021-09638-z
M3 - Article
C2 - 33651215
AN - SCOPUS:85102055276
SN - 1068-9265
VL - 28
SP - 3009
EP - 3010
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 6
ER -